openPR Logo
Press release

Digital Health to drive the Progressive Multifocal Leukoencephalopathy Treatment Market from 2017-2026, reaching US$ 150.5 Mn

04-18-2022 10:42 AM CET | Health & Medicine

Press release from: Persistence Market Research

Digital Health to drive the Progressive Multifocal

The Progressive Multifocal Leukoencephalopathy Treatment Market is all set to unleash its potential to the fullest, reaching US$ 150.5 Mn at a CAGR of 2.8%. The new normal constitutes video chatting with therapists. The patients are thus able to create their profile and look for the therapist (s) of their choice. Patients could, thus share the data from various apps and share it with their provider (s) for a better understanding of the personalized care needed by them. Such would be the healthcare vertical.

Progressive multifocal leukoencephalopathy (PML) is a rare, fatal disease that causes continual damage to the white matter of the brain, at different locations. Caused by JC Virus, PML is mostly reported in cancer patients on chronic immunosuppressive medications or those suffering from AIDS. Also, patients with transplants, multiple sclerosis or other variants of autoimmune diseases are susceptible to progressive multifocal leukoencephalopathy.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/15679

With no specific treatment, anti-HIV drugs are being increasingly used for controlling progressive multifocal leukoencephalopathy. Considering the rarity of the disease, with no specific treatment options available, the global progressive multifocal leukoencephalopathy treatment market is expected to remain in the low growth-low volume quadrant over the forecast period of 2018-2026, representing a sluggish 2.8% CAGR, predicts Persistence Market Research.

Company Profile

Pfizer, Inc.
Hoffman - La Roche Ltd.
Gilead Sciences, Inc.
GlaxoSmithKline plc
Sanofi S.A.
Allergan plc (Actavis plc)
Overview
Novartis AG
Mylan N.V.
AbbVie Inc.

The global progressive multifocal leukoencephalopathy treatment market is likely to reach a valuation of US$ 150.5 Mn by 2026 by the end of 2026. While the North America progressive multifocal leukoencephalopathy treatment market is anticipated to be the most lucrative, PML market in Asia Pacific is expected to record comparatively faster growth considering increasing prevalence of HIV infection and awareness.

Anti-retroviral therapy, Anti JCV, and other symptomatic drugs for progressive multifocal leukoencephalopathy treatment are available in the market. Symptomatic treatment of progressive multifocal leukoencephalopathy is projected to hold +32% market share in 2018, with significant revenue contribution to the global progressive multifocal leukoencephalopathy treatment market. The trend is closely followed by Anti-retroviral therapy, given to the newly diagnosed patients with HIV infection and PML.

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/15679

Swelling HIV & Hematological Malignancy Prevalence to Boost Progressive Multifocal Leukoencephalopathy Treatment Market

Increasing prevalence of HIV infection and cancer is expected to boost the growth of global progressive multifocal leukoencephalopathy treatment market. In terms of indication, HIV/AIDS and hematological malignancies collectively accounted for a total value share of +87% of the global progressive multifocal leukoencephalopathy treatment market in 2017.

Despite advancements in scientific understanding of HIV and its prevention and treatment coupled with significant efforts by government and civil society organizations, most patients living with HIV or at risk of contracting infection, do not have access to optimal prevention, care, and treatment, more so in middle and low income economies.

Delayed treatment exposes patients to more fatal diseases like progressive multifocal leukoencephalopathy. Studies show that approximately 80% of progressive multifocal leukoencephalopathy patients have AIDS. Use of antiretroviral therapy for HIV-infected patients is expected to boost the global progressive multifocal leukoencephalopathy treatment market.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/15679

Moreover, growing prevalence of hematological malignancy and early diagnosis of PML as a first line of treatment are key factors promoting the global progressive multifocal leukoencephalopathy treatment market. PML is mostly reported in patients suffering from homological malignancy, solid tumors, and in organ transplant recipients.

Since, overall healthcare investments have significantly increased, across the globe, governments are making efforts to deliver quality treatment and care to HIV patients, typically antiretroviral therapy. Favorable reimbursements and insurance options for HIV and cancer treatment and people with pre-existing HIV conditions, will not just provide financial assistance in low and middle income economies, but also help in early diagnosis of PML, further driving the global progressive multifocal leukoencephalopathy treatment market.

Complete Report Details@ https://www.persistencemarketresearch.com/market-research/progressive-multifocal-leukoencephalopathy-treatment-market.asp

Cost-effective diagnosis and treatment camps by Centers for Disease Control and Prevention (CDCP) would further contribute to the global growth of progressive multifocal leukoencephalopathy treatment market.

"Lack of specific treatments and therapies for progressive multifocal leukoencephalopathy treatment is likely to restrict the market growth, considering poor outcomes of the treatment. The current progressive multifocal leukoencephalopathy treatment options focus on immune reconstitution, restoration of immune responses to JC virus infection, and eventual suppression of immune reconstitution inflammatory syndrome"-

Related Reports:

Immunooncology Market - https://www.persistencemarketresearch.com/market-research/immunooncology-market.asp

U.S Bacterial Conjunctivitis Drugs Market - https://www.persistencemarketresearch.com/market-research/u.s-bacterial-conjunctivitis-drugs-market.asp

Contact Us:

Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com
Website - https://www.persistencemarketresearch.com

About Us:

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers' experience by acting as the "missing" link between "customer relationships" and "business outcomes'. The best possible returns are assured therein.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Digital Health to drive the Progressive Multifocal Leukoencephalopathy Treatment Market from 2017-2026, reaching US$ 150.5 Mn here

News-ID: 2604802 • Views:

More Releases from Persistence Market Research

Compostable Pouch Market to Grow from US$238 Million in 2024 to US$344 Million by 2031
Compostable Pouch Market to Grow from US$238 Million in 2024 to US$344 Million b …
The global compostable pouch market is experiencing significant growth, driven by increasing consumer demand for sustainable packaging solutions and stringent regulations on plastic waste. This article explores the factors contributing to this growth, the market's segmentation, and the key players shaping the industry's future. According to Persistence Market Research, the global compostable pouch market is forecast to expand at a compound annual growth rate (CAGR) of 5.4%, increasing from an estimated
PDC Drill Bits Market to Reach US$5.7 Billion by 2031 with 4.6 Percent CAGR Key Growth Drivers and Market Insights
PDC Drill Bits Market to Reach US$5.7 Billion by 2031 with 4.6 Percent CAGR Key …
The Polycrystalline Diamond Compact drill bits market has been witnessing notable growth over recent years, driven by the increasing demand for efficient drilling solutions in the oil, gas, and mining industries. PDC drill bits, recognized for their durability and high performance, are widely used for both conventional and unconventional drilling applications. The global energy sector's evolution, technological advancements, and rising exploration activities are key factors shaping the market trajectory. This
Blister Packaging Market Growth Driven by Rising Demand for Secure and Sustainable Packaging Solutions | Valued at US$24.7 Bn in 2025
Blister Packaging Market Growth Driven by Rising Demand for Secure and Sustainab …
The global blister packaging market is witnessing significant expansion as industries increasingly prioritize product protection, tamper resistance, and sustainability. According to the latest study by Persistence Market Research, the global blister packaging market size is likely to be valued at US$24.7 Bn in 2025 and is estimated to reach US$39.7 Bn by 2032, growing at a CAGR of 7.0% during the forecast period of 2025-2032. The growing adoption of blister
Clamshell Labelling Machines Market Driven by Rising Food Packaging Demand to Reach US$339.6 Mn by 2031
Clamshell Labelling Machines Market Driven by Rising Food Packaging Demand to Re …
Clamshell Labelling Machines Market Driven by Rising Food Packaging Demand to Reach US$339.6 Mn by 2031 According to the latest study by Persistence Market Research, the global clamshell labelling machines market is projected to grow steadily at a CAGR of 4.4% between 2024 and 2031. The market is expected to rise from an estimated US$251.2 million in 2024 to approximately US$339.6 million by 2031. This growth is primarily fueled by the

All 5 Releases


More Releases for HIV

HIV Drugs Market - Defeating HIV Together: Advancing Treatment Options for a Bri …
Newark, New Castle, USA: The "HIV Drugs Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors HIV Drugs Market: https://www.growthplusreports.com/report/hiv-drugs-market/7792 This latest report researches the industry structure, sales, revenue,
HIV-Associated Lipodystrophy Treatment Market - Increasing prevalence of HIV is …
HIV-associated lipodystrophy also known as lipodystrophy is a syndrome that occurs in HIV-infected patients. It is characterized by loss of subcutaneous fat from face, buttocks, arms and legs. Although the exact cause of HIV-associated lipodystrophy is not fully elucidated, some research evidence reported that it occurs in HIV-infected patients who are under antiretroviral medications. According to an article published in National Center for Biotechnology Information (NCBI) in 2014, prevalence of
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication
HIV Therapeutics Market– South Africa's Aspen launches three-in-one HIV drug
Recent Developments Aspen Pharma care, a South Africa’s drug maker has launched a triple combination of tablet for the treatment of HIV in the country where the HIV virus is the most prevalent. The company's new Emdolten drug is a once a day tablet which is in the form of dolutegravir, an antiretroviral medication that balances the drug’s resistance. The company has launched Aspen Stavudine which was its first generic ARV
HIV Vaccine Market HIV Vaccine Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Introduction to Human Immunodeficiency Virus (HIV) Vaccines 1.1 Overview 1.2 Antiquity of HIV Vaccine Need for the Development of HIV Vaccine Primer of HIV inside the Body 3.1 Inclusion of HIV Virus into the System 3.2 Interaction of HIV with Host 3.3 Eradication of HIV Virus HIV Vaccine Development Process 4.1 Introduction
Global HIV Vaccine Market & HIV Vaccine Clinical Trial Outlook 2022
Worldwide, around the 35 Million of the people are currently infected with the HIV and about 30 Million of the people died because of the AIDS infection. There is no human example of clearing an HIV infection naturally. HIV virus makes copies of it very quickly, many types of HIV exist and new types of virus are continue to rise. Many scientists are still trying to understand the specific ways